The global trade landscape is undergoing significant changes following the announcement of new reciprocal tariffs by the United States government. Recent developments indicate significant shifts in global trade dynamics, with key policy adjustments, ongoing negotiations, and evolving logistics patterns. Below is a summary of the latest developments.
1. Extension of U.S. – EU Tariff Deadline
The United States has postponed the implementation of a proposed 50% tariff on European Union goods from June 1 to July 9, 2025, allowing additional time for trade negotiations. This decision follows discussions between U.S. and EU officials aimed at resolving trade tensions.
2. U.S. – India Trade Negotiations Continue
High-level trade talks between the United States and India continued in Washington, D.C., with both sides aiming to finalize the first phase of a bilateral trade agreement before the expiration of the 90-day tariff pause in early July. Discussions have focused on tariff exemptions and enhancing market access
3. U.S. – Korea Trade Update
The United States and South Korea are working toward a comprehensive trade agreement, informally known as the “July Package,” targeted for completion by July 8, 2025. The framework aims to resolve tariff disputes and address longstanding trade imbalances.
Reference:
US Tariffs Updates Impact Global Trade
Today we announce that Exim is rebranding as ExSyn. We are presenting a new brand identity and website as a reflection of our relentless transformation over the course of 30 years serving the pharma and chemical industries. The new brand builds upon our core strengths as a sourcing company and captures our most essential duty: helping improve people’s health and lives.
Adenosine is a naturally occurring purine nucleoside composed of adenine and ribose, present in all living cells. It plays a vital role in biochemical processes such as energy transfer (ATP/ADP), signal transduction, and regulation of physiological functions, and is widely used in pharmaceutical applications.
Methyl-2-Methoxy-5-Sulfamoyl Benzoate (MSMB) is a sulfur containing organic building block acting as a chemical intermediate. MSMB contains ester and sulfamoyl functional groups, which make it useful as a pharmaceutical and fine-chemical intermediate.
The European Union (EU) has agreed to offer Indian pharmaceutical and medical devices companies preferential access to EU market, along with cutting tariffs on 97.5 percent of chemical products to zero.